Incidence of IBD 10.9 Per 100,000 Person-Years in the United States
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, July 25, 2023 -- The incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and prevalence is 721 per 100,000 population, according to a study published online July 20 in Gastroenterology.
James D. Lewis, M.D., from the University of Pennsylvania in Philadelphia, and colleagues estimated the incidence, prevalence, and racial-ethnic distribution of physician-diagnosed IBD in the United States using four administrative claims datasets. Validated combinations of medical diagnoses, diagnostic procedures, and prescription medications were used to identify incident and prevalent diagnoses.
The researchers found that the age- and sex-standardized incidence of IBD was 10.9 per 100,000 person-years. In the third decade of life, incidence of IBD peaked, followed by a decrease to a relatively stable level across the fourth to eighth decades, and a further decline. Per 100,000 population, the age-, sex-, and insurance-standardized prevalence of IBD was 721. An estimated 2.39 million Americans were diagnosed with IBD extrapolated to the 2020 census. IBD prevalence was 812, 504, 403, and 458 per 100,000 population in White, Black, Asian, and Hispanic Americans, respectively.
"Accurate estimates of IBD incidence and prevalence taking into account racial and ethnic distribution are crucial because they provide valuable information about the burden of disease in a population," a coauthor said in a statement. "This is the most comprehensive study to date and this knowledge is essential to help health care professionals and policy makers allocate resources to effectively manage IBD, make better-informed public health decisions, and improve patient outcomes."
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease
FRIDAY, May 3, 2024 -- Among postmenopausal women with inflammatory bowel disease (IBD), there is no higher risk for cardiovascular disease (CVD) compared with women without IBD...
Study IDs Risk Factors for Extraintestinal Manifestations of IBD
WEDNESDAY, April 17, 2024 -- Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD)...
Higher Vitamin D Levels Cut Bowel Resection Risk With IBD
WEDNESDAY, April 3, 2024 (HealthDay News) -- An increased serum level of 25-hydroxyvitamin D (25[OH]D) is independently associated with a lower risk for bowel resection with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.